Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/25/2015 03/26/2015 03/27/2015 03/30/2015 03/31/2015 Date
175.63(c) 176.04(c) 180.59(c) 180.26(c) 173.3(c) Last
1 399 692 1 593 367 1 450 673 1 180 232 1 824 138 Volume
-4.26% +0.23% +2.58% -0.18% -3.86% Change
More quotes
Financials ($)
Sales 2015 2 636 M
EBIT 2015 1 310 M
Net income 2015 918 M
Finance 2015 2 858 M
Yield 2015 -
Sales 2016 3 283 M
EBIT 2016 1 731 M
Net income 2016 1 201 M
Finance 2016 4 309 M
Yield 2016 -
PER 2015 39,95
PER 2016 29,67
EV / Sales 2015 12,2x
EV / Sales 2016 9,36x
Capitalization 35 032 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
04/23Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
03/26 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
03/16 ALEXION PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminatio..
03/10 ALEXION PHARMACEUTICALS : Coverage of Biotech Equities -- MannKind, Novavax, Cur..
03/09 ALEXION PHARMACEUTICALS : FDA Grants Priority Review for Asfotase Alfa as a Trea..
03/07 ALEXION PHARMACEUTICALS : New Data from First Natural History Study in Juveniles..
03/05 ALEXION PHARMACEUTICALS : FDA Grants Priority Review for Asfotase Alfa as a Trea..
03/02 ALEXION PHARMACEUTICALS : FDA Grants Priority Review for Asfotase Alfa as a Trea..
03/01 ALEXION PHARMACEUTICALS : Joins Patient Organizations Worldwide in Support of In..
More news
Sector news : Biopharmaceuticals
06:01a VALEANT PHARMACEUTICALS INTL : International, Inc. : Completes Tender Offer For ..
05:36a BAYER : HealthCare Expands Co-Development Agreement with Broad Institute for Car..
04:25a KYOWA HAKKO KIRIN : Entries Now Publicly Available from the 'Commitment to Life'..
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/31 Strong Dollar Hurts Profit Forecasts In Long Term
03/02 BIOGEN IDEC : A Great Company, But Not An Alpha Opportunity
03/02 Investors Are Best To Avoid The iShares Nasdaq Biotechnology ETF (IBB)
03/02 FDA grants Priority Review for Alexion's application for asfotase alfa
03/02 Citigroup and Visa take AmEx's spot with Costco


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF